CBD is “too big to fail,” and the US is getting on board: YES WE CANNABIDIOL


Given the FDA’s recent letter, I’m thinking that the celebration may be premature.

The FDA is essentially saying, because CBD is in an FDA approved pharmaceutical, it cannot be added to consumables without requisite FDA clinical trials, especially if you’re going to try to make any health claims.

If that’s confusing, think of it this way: Aspirin is made from the bark of a tree. Aspirin is an FDA approved medication (over-the-counter, but the distinction isn’t important). You cannot put Aspirin into any old thing and just sell it without approval, especially if you’re making health claims for which there’s no clinical evidence.

This statement deals with health claims of CBD:

The FDA requires a cannabis product (hemp-derived or otherwise) that is marketed with a claim of therapeutic benefit, or with any other disease claim, to be approved by the FDA for its intended use before it may be introduced into interstate commerce.

and this deals with CBD food additives:

Additionally, it’s unlawful under the FD&C Act to introduce food containing added CBD or THC into interstate commerce, or to market CBD or THC products as, or in, dietary supplements, regardless of whether the substances are hemp-derived. Weirdly, they mention THC as well. It’s weird because there is no FDA approved medication that contains THC. There’s Marinol, but that’s synthetic THC.